Our proposed Research Program Project (PPG): The SCRIPPS Research in-MethAmphetamine-NeuroAIDS Research Program (TSRI-MANARP) seeks to determine in select animal models, the neurotoxic infection with methamphetamine (METH) neuropharmacology. Using pre-clinical models (mice, felines and macaques), we will determine the location, biological course, and functional consequence of what we hypothesize to be common pathological processes leading to a more fulminant viral injection and functional decline in treated animals. We believe that only by employing the controlled experimental settings provided in the proposed experimental plan will the precise biological interactions and risk factors for pathology be discerned. Employing three well established animal models of neuro-AIDS we propose to investigate several methamphetamine neuropharmacology and NeuroAIDS-related neurotoxicity. Each animal model brings to convergence of these toxic phenotypes. Preliminary data included with the revised application provides new evidence for synergy in METH neuropharmacology and HIV-1 pathogenesis; evidence that is bolstered by theme to investigate the role of methamphetamine on disease progression and functional pathology in our documented high risk behaviors for HIV-1 exposure associated with methamphetamine abuse; 2. The converging evidence of both sub-cortical and cortical pathologies independently associated with both agents; 3. The evidence of direct actions of amphetamines on immune status, and 4. The woeful under representation of cellular, behavioral, and pathophysiological studies in this area.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA012444-04
Application #
6634261
Study Section
Special Emphasis Panel (ZDA1-RXL-E (16))
Program Officer
Frankenheim, Jerry
Project Start
2000-09-30
Project End
2005-05-31
Budget Start
2003-06-01
Budget End
2004-05-31
Support Year
4
Fiscal Year
2003
Total Cost
$1,888,147
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Huitron-Resendiz, Salvador; Henriksen, Steven J; Barr, Margaret C et al. (2010) Methamphetamine and lentivirus interactions: reciprocal enhancement of central nervous system disease. J Neurovirol 16:268-78
Sanchez-Alavez, Manuel; Conti, Bruno; Moroncini, Gianluca et al. (2007) Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. Brain Res 1158:71-80
Persidsky, Yuri; Fox, Howard (2007) Battle of animal models. J Neuroimmune Pharmacol 2:171-7
Milner, Richard; Campbell, Iain L (2006) Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system. Mol Cell Neurosci 33:429-40
Criado, Jose R; Sanchez-Alavez, Manuel; Conti, Bruno et al. (2005) Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 19:255-65
Madden, Lisa J; Flynn, Claudia T; Zandonatti, Michelle A et al. (2005) Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology 30:350-9
Balosso, Silvia; Ravizza, Teresa; Perego, Carlo et al. (2005) Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol 57:804-12
Huitron-Resendiz, Salvador; Kristensen, Morten P; Sanchez-Alavez, Manuel et al. (2005) Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 25:5465-74
Vlkolinsky, Roman; Siggins, George R; Campbell, Iain L et al. (2004) Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices. J Neuroimmunol 150:37-47
Crocker, Stephen J; Pagenstecher, Axel; Campbell, Iain L (2004) The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res 75:1-11

Showing the most recent 10 out of 26 publications